Microsoft, National Minority Quality Forum launch trial network

The National Minority Quality Forum has launched a collaboration between its National Health Index (NHI) and Microsoft to launch the National Clinical Trial Network (NCTN) designed to address challenges in clinical trials.

The relationship allows NCTN to deliver a platform that provides a database of clinical trial options to providers.

The network also will be a data warehouse (patient registries, bio banks and community-level health statistics), transforming isolated data repositories into an integrated, searchable, national archive, permitting the identification of representative samples of risk populations who might benefit from a proposed therapy.

NCTN said it will maintain searchable profiles of clinical research institutions, experienced clinical investigators and those interested in being a clinical researcher. Its investigator registry will provide background information on investigators, their practices and the communities that they serve.

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.